Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HIG | Common Stock | Options Exercise | $875K | +36.2K | +25.29% | $24.15 | 180K | Nov 30, 2022 | Direct | |
transaction | HIG | Common Stock | Sale | -$2.76M | -36.2K | -20.19% | $76.17 | 143K | Nov 30, 2022 | Direct | F1, F2 |
holding | HIG | Common Stock | 43.2K | Nov 30, 2022 | By Spouse | ||||||
holding | HIG | Common Stock | 95.4K | Nov 30, 2022 | Swift Family Gift Trust | ||||||
holding | HIG | Common Stock | 60.9K | Nov 30, 2022 | Swift Family Legacy Trust |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HIG | Stock Option | Options Exercise | $0 | -36.2K | -100% | $0.00* | 0 | Nov 30, 2022 | Common Stock | 36.2K | $24.15 | Direct | F3 |
holding | HIG | Stock Option | 104K | Nov 30, 2022 | Common Stock | 104K | $35.83 | Direct | F4 | |||||
holding | HIG | Stock Option | 302K | Nov 30, 2022 | Common Stock | 302K | $41.25 | Direct | F5 | |||||
holding | HIG | Stock Option | 294K | Nov 30, 2022 | Common Stock | 294K | $43.59 | Direct | F6 | |||||
holding | HIG | Stock Option | 303K | Nov 30, 2022 | Common Stock | 303K | $48.89 | Direct | F7 | |||||
holding | HIG | Stock Option | 352K | Nov 30, 2022 | Common Stock | 352K | $49.01 | Direct | F8 | |||||
holding | HIG | Stock Option | 311K | Nov 30, 2022 | Common Stock | 311K | $51.87 | Direct | F9 | |||||
holding | HIG | Stock Option | 285K | Nov 30, 2022 | Common Stock | 285K | $53.81 | Direct | F10 | |||||
holding | HIG | Stock Option | 328K | Nov 30, 2022 | Common Stock | 328K | $55.27 | Direct | F11 | |||||
holding | HIG | Stock Option | 302K | Nov 30, 2022 | Common Stock | 302K | $69.41 | Direct | F12 |
Id | Content |
---|---|
F1 | The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on March 15, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2013 and scheduled to expire on March 5, 2023. |
F2 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $76.00 - $76.40 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F3 | The options became fully exercisable on March 5, 2016, the third anniversary of the grant date. |
F4 | The options became fully exercisable on March 4, 2017, the third anniversary of the grant date. |
F5 | The options became fully exercisable on March 3, 2018, the third anniversary of the grant date. |
F6 | The options became fully exercisable on March 1, 2019, the third anniversary of the grant date. |
F7 | The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. |
F8 | The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. |
F9 | One-third of the options became exercisable on February 23, 2022, an additional one-third of the options will become exercisable on February 23, 2023 and the remaining one-third of the options will become exercisable on February 23, 2024, the third anniversary of the grant date. |
F10 | The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. |
F11 | One-third of the options became exercisable on February 25, 2021, an additional one-third of the options became exercisable on February 25, 2022 and the remaining one-third of the options will become exercisable on February 25, 2023, the third anniversary of the grant date. |
F12 | One-third of the options will become exercisable on February 23, 2023, an additional one-third of the options will become exercisable on February 23, 2024 and the remaining one-third of the options will become exercisable on February 23, 2025, the third anniversary of the grant date. |